FDA Approves Ketamine-derived Nasal Spray for Depression Technology Networks
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of ...
View full coverage on Google News (CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment